Literature DB >> 18162234

T cell therapy in allogeneic stem cell transplantation.

J H Frederik Falkenburg1, Helen E Heslop, A John Barrett.   

Abstract

Mesh：

Year:  2008        PMID： 18162234      PMCID： PMC3426445          DOI： 10.1016/j.bbmt.2007.10.022

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  27 in total

1.  Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

Authors:  Karl S Peggs; Stephanie Verfuerth; Arnold Pizzey; Naeem Khan; Malcolm Guiver; Paul A Moss; Stephen Mackinnon
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

2.  Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.

Authors:  S R Solomon; T Tran; C S Carter; S Donnelly; N Hensel; J Schindler; E Bahceci; V Ghetie; J Michálek; D Mavroudis; E J Read; E S Vitetta; A J Barrett
Journal:  Cytotherapy       Date:  2002       Impact factor: 5.414

3.  Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

Authors:  Hermann Einsele; Eddy Roosnek; Nathalie Rufer; Christian Sinzger; Susanne Riegler; Jürgen Löffler; Ulrich Grigoleit; Arnaud Moris; Hans-Georg Rammensee; Lothar Kanz; Annette Kleihauer; Friederike Frank; Gerhard Jahn; Holger Hebart
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 4.  Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia.

Authors:  J H Frederik Falkenburg; Roel Willemze
Journal:  Best Pract Res Clin Haematol       Date:  2004-09       Impact factor: 3.020

5.  Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.

Authors:  Benny J Chen; Xiuyu Cui; Congxiao Liu; Nelson J Chao
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

6.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

Authors:  W A Erik Marijt; Mirjam H M Heemskerk; Freke M Kloosterboer; Els Goulmy; Michel G D Kester; Menno A W G van der Hoorn; Simone A P van Luxemburg-Heys; Manja Hoogeboom; Tuna Mutis; Jan Wouter Drijfhout; Jon J van Rood; Roel Willemze; J H Frederik Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

7.  Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study.

Authors:  Isabelle André-Schmutz; Françoise Le Deist; Salima Hacein-Bey-Abina; Ellen Vitetta; John Schindler; Gaelle Chedeville; Etienne Vilmer; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

8.  Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Authors:  Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

9.  Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

Authors:  Katayoun Rezvani; Matthias Grube; Jason M Brenchley; Giuseppe Sconocchia; Hiroshi Fujiwara; David A Price; Emma Gostick; Ko Yamada; Jan Melenhorst; Richard Childs; Nancy Hensel; Daniel C Douek; A John Barrett
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

10.  Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.

Authors:  Mirjam H M Heemskerk; Manja Hoogeboom; Renate Hagedoorn; Michel G D Kester; Roel Willemze; J H Frederik Falkenburg
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307
View more
  4 in total

1.  Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

Authors:  Conrad Russell Cruz; Patrick J Hanley; Hao Liu; Vicky Torrano; Yu-Feng Lin; James A Arce; Stephen Gottschalk; Barbara Savoldo; Gianpietro Dotti; Chrystal U Louis; Ann M Leen; Adrian P Gee; Cliona M Rooney; Malcolm K Brenner; Catherine M Bollard; Helen E Heslop
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

2.  HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.

Authors:  W Herr; Y Eichinger; J Beshay; A Bloetz; S Vatter; C Mirbeth; E Distler; U F Hartwig; S Thomas
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

3.  Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.

Authors:  Christian M Capitini; Nicole M Nasholm; Brynn B Duncan; Martin Guimond; Terry J Fry
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

Review 4.  The 'cytokine storm': molecular mechanisms and therapeutic prospects.

Authors:  Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2021-07-01       Impact factor: 19.709
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.